COVID-19 Clinical Trials in South West Sydney

COVID-19 Research and its Impact on our Community

Since March, the Institute has established 17 clinical trials on COVID-19 across the local health district, including:

COVID-19 Intervention
Exploring the treatment and prevention of COVID-19, including new treatments and current medications for people being cared for at home, in hospital and in intensive care.

COVID-19 Data Collection
Collecting data that is providing insights into COVID-19 locally, nationally and internationally, including for the World Health Organisation (WHO). This data allows representation of our south west Sydney population and drives our knowledge in the disease, health care needs and ongoing impact of COVID-19.

COVID-19 Mental Health Impacts
Looking at how people have reacted in a pandemic state to inform future care if/when a pandemic or health crisis of this magnitude happens again. This clinical trial will study the impacts of lockdown and community impacts such as remote learning in schools and universities. The data collection will inform how we look after mental health across our diverse population and the vulnerable in our community.

COVID-19 Remote Sensor Patient Monitoring
Using remote sensor technology, this study will capture the patient critical biometrics via an arm band worn 22–23 hrs/day. Patient information including respiratory rate, heart rate, temperature and oxygen saturation is automatically monitored and recorded, triggering an alert directly to the Triple I Hub for immediate intervention. This technology is a non-intrusive way to manage COVID-19 in the community, while minimising the risk of further exposure for non-acute patients going into hospital.